|
|
||||||||
Departments of Hematology, Neurology, and Pathology, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
We report the presenting neurologic and visual symptoms in 17 patients with primary thrombocythemia. Poorly localizing symptoms occurred in 14 patients: transient unsteadiness in 13, dysarthria in eight, and scintillating scotomata in four. Nine patients had focal symptoms: transient monocular blindness in two patients, transient mono- or hemiparesis in six, and both of these in one patient. The attacks all had a sudden onset, occurred sequentially rather than simultaneously, lasted for a few seconds to several minutes, and were usually associated with a dull or pulsatile headache. A causal platelet-mediated arterial thrombosis was evident in 15 patients. There were no recurrences of thrombotic or ischemic events during long-term treatment of 12 patients with aspirin and during cytostatic reduction of platelet count to normal in seven patients. We conclude that low-dose aspirin and reduction of platelet count to normal are effective, but coumarin is ineffective, in the treatment and prevention of arterial thrombosis in thrombocythemia.
Address correspondence and reprint requests to Dr. Jan J. Michiels, Department of Hematology, University Hospital Dijkzigt, 40 Dr Molewaterplein, 3015 GD Rotterdam, The Netherlands.
Received July 7,1992. Accepted for publication in final form October 2, 1992.
This article has been cited by other articles:
![]() |
L. I. Kornblihtt, S. Cocorullo, C. Miranda, P. Lylyk, P. G. Heller, and F. C. Molinas Moyamoya Syndrome in an Adolescent With Essential Thrombocythemia: Successful Intracranial Carotid Stent Placement Stroke, August 1, 2005; 36(8): e71 - e73. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Spivak Polycythemia vera: myths, mechanisms, and management Blood, December 15, 2002; 100(13): 4272 - 4290. [Full Text] [PDF] |
||||
![]() |
M. S. Laguna, L. I. Kornblihtt, R. F. Marta, J. J. Michiels, and F. C. Molinas State-of-the-Art Review : Effectiveness of Anagrelide in the Treatment of Symptomatic Patients with Essential Thrombocythemia Clinical and Applied Thrombosis/Hemostasis, July 1, 2000; 6(3): 157 - 161. [Abstract] [PDF] |
||||
![]() |
J. J. Michiels Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(4): 247 - 251. [Abstract] [PDF] |
||||
![]() |
J. J. Michiels Acquired von Willebrand Disease Due to Increasing Platelet Count Can Readily Explain the Paradox of Thrombosis and Bleeding in Thrombocythemia Clinical and Applied Thrombosis/Hemostasis, July 1, 1999; 5(3): 147 - 151. [Abstract] [PDF] |
||||
![]() |
J. J. Michiels Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential Thrombocythemia Clinical and Applied Thrombosis/Hemostasis, January 1, 1999; 5(1): 30 - 36. [Abstract] [PDF] |
||||
![]() |
P. van Genderen, J. J. Michiels, T. Ring, R. H. Feiner, S. Cortelazzo, G. Finazzi, and T. Barbui Hydroxyurea in Essential Thrombocytosis N. Engl. J. Med., September 21, 1995; 333(12): 802 - 803. [Full Text] |
||||
![]() |
P. J. J. van Genderen and J. J. Michiels Arterial Thrombophilia in Primary Thrombocythemia: A Case Report Angiology, June 1, 1994; 45(6): 485 - 488. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |